1. Home
  2. ZYME vs PRDO Comparison

ZYME vs PRDO Comparison

Compare ZYME & PRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$25.80

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Perdoceo Education Corporation

PRDO

Perdoceo Education Corporation

HOLD

Current Price

$28.19

Market Cap

2.3B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZYME
PRDO
Founded
2003
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
ZYME
PRDO
Price
$25.80
$28.19
Analyst Decision
Strong Buy
Buy
Analyst Count
9
1
Target Price
$28.50
$42.00
AVG Volume (30 Days)
1.8M
841.9K
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
2.13%
EPS Growth
N/A
17.26
EPS
N/A
2.33
Revenue
$134,481,000.00
$810,888,000.00
Revenue This Year
$64.45
$26.43
Revenue Next Year
$67.04
$3.65
P/E Ratio
N/A
$12.11
Revenue Growth
116.21
24.23
52 Week Low
$9.03
$23.87
52 Week High
$28.49
$38.03

Technical Indicators

Market Signals
Indicator
ZYME
PRDO
Relative Strength Index (RSI) 63.18 34.23
Support Level $24.83 $27.56
Resistance Level $27.49 $28.59
Average True Range (ATR) 1.32 0.90
MACD -0.03 0.17
Stochastic Oscillator 60.00 45.21

Price Performance

Historical Comparison
ZYME
PRDO

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

About PRDO Perdoceo Education Corporation

Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.

Share on Social Networks: